Hilton Grand Vacations stock price target raised to $73 by Mizuho

Mizuho raised its price target on Hilton Grand Vacations (HGV) to $73 and maintained an Outperform rating, citing improved Bluegreen upgrade sales and resolved sales force issues. This positive outlook comes despite HGV's recent Q1 2025 earnings missing forecasts, though the company maintained its full-year adjusted EBITDA guidance and completed a $300 million timeshare loan securitization. Analyst sentiment remains mixed, reflecting differing views on HGV's future prospects despite these strategic advancements.

Analysis

Mizuho has increased its price target for Hilton Grand Vacations (HGV) to $73 from $70, maintaining an Outperform rating, predicated on the successful integration and upgrade sales from the Bluegreen acquisition and the resolution of prior sales force issues. The firm highlights a significant growth opportunity, noting that legacy Bluegreen owners historically converted at only half the rate of HGV's, a gap the new HGV Max portfolio is expected to close. This optimism, however, is set against a backdrop of poor recent performance, as HGV's first-quarter 2025 results significantly underperformed expectations, with EPS of $0.09 versus a $0.59 forecast and revenue of $1.15 billion missing the anticipated $1.25 billion. Despite this, management reaffirmed its full-year adjusted EBITDA guidance, signaling confidence in its strategy. This confidence is partly supported by a recently completed $300 million securitization of timeshare loans, which indicates strong investor demand for its credit. The analyst community remains sharply divided, with Goldman Sachs holding a Sell rating and a $34 price target, directly contradicting the bullish theses of Mizuho and JMP Securities, thereby reflecting substantial uncertainty regarding HGV's near-term execution capabilities.

Key Decisions for Investors

• Investors must weigh the potential long-term value from the Bluegreen customer upgrade strategy against the significant execution risk highlighted by the recent Q1 2025 earnings miss.
• For those confident in management's ability to achieve its reaffirmed full-year EBITDA guidance, the current stock price may represent a buying opportunity, aligning with the bullish outlook from analysts like Mizuho.
• Given the starkly divided analyst ratings, particularly the Sell rating from Goldman Sachs, risk-averse investors should monitor upcoming quarterly results for concrete data on Bluegreen synergy realization before increasing their position.
• Closely track contract sales and upgrade conversion rates from the legacy Bluegreen segment, as these metrics are the primary catalysts that must materialize to validate the bull case for the stock.